Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
1 other identifier
interventional
52
1 country
1
Brief Summary
Adolescents and young adults (AYAs; ages 17-23) with type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control and disengagement from the health care system. The deterioration of glycemic control occurs in parallel with the assumption of independent self-care skills and preparation for adult diabetes care. Effective communication between AYAs and health care providers may be a critical contributor to diabetes self-care skills during the transition to adult diabetes care and related glycemic control. This research will attempt to better prepare adolescents and young adults for adult diabetes care by delivering innovative intervention content focused on both health communication skills and transition readiness skills. The investigators aim to leverage innovative technologies to improve developmentally-appropriate communication skills related to planning for clinic visits, disclosing and discussing diabetes-related concerns, and optimizing glucose data review in preparation for adult diabetes care. Adolescents and young adults with type 1 diabetes (ages 17-23) who are planning to transition to adult diabetes care within the next 6-8 months will be enrolled in the study and randomized to either the intervention group or a standard care control group. Medical, communication and psychosocial data (including A1c, glucose monitoring frequency, communication quality, health care engagement, depressive symptoms) will be collected from adolescent and young adult participants and health care providers at baseline and two follow-up time points, approximately 4 months post-baseline and approximately 8-12 months post-baseline after the transfer to adult diabetes care. This intervention has the potential to improve diabetes self-care skills, including engagement with health care providers, and glycemic control in AYAs with type 1 diabetes during the vulnerable period of transfer to adult diabetes care. The results of this work will inform best practices for the transition to adult diabetes care and can be translated into clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2018
CompletedStudy Start
First participant enrolled
November 6, 2018
CompletedFirst Posted
Study publicly available on registry
November 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2026
CompletedResults Posted
Study results publicly available
May 5, 2026
CompletedMay 5, 2026
May 1, 2026
5.1 years
November 1, 2018
February 19, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Hemoglobin A1c
percentage of glycated hemoglobin (Hemoglobin A1c)
8 months post-baseline
Number of Days to First Adult Diabetes Care Visit
Number of days between the last visit in pediatric diabetes care and the first visit in adult diabetes care (reported as number of days).
8 months post-baseline
Adherence to the Diabetes Care Regimen
Participant report on the Diabetes Management Questionnaire (DMQ), a self-report measure of adherence to the diabetes care regimen. The DMQ consists of 20 items scored on a 0-4 Likert Scale. The measure has a total score; the mean score on all items is calculated and multiplied by 25 to arrive at the total score (possible range 0-100). A higher score indicates greater adherence to diabetes management.
8 months post-baseline
Diabetes-related Hospitalizations
Participant report and medical record review of reported diabetes-related hospitalizations for the duration of the study period. The total number of diabetes-related emergency department visits/hospitalizations is summed.
8 months post-baseline
Study Arms (2)
PREP-DC Intervention
EXPERIMENTAL50 participants will be randomized to the Plan, Reflect, and Engage with Providers for Diabetes Care (PREP-DC) intervention. Participants will complete 3 intervention sessions with study interventionists and will receive text messages and other study resources during the active intervention period (3 months).
Standard Care Comparison
NO INTERVENTION50 participants will be randomized to standard care and will participate in regular diabetes clinic visits and receive standard materials on the transition to adult diabetes care, as they would have done without participation in this study.
Interventions
Behavioral intervention designed to improve health communication skills and readiness for adult diabetes care
Eligibility Criteria
You may qualify if:
- Diagnosed with type1 diabetes for ≥ 1 year
- Able to adequately understand, speak, and read English to benefit from participation
- Ready and consistent text messaging access to participate
- Within 6-8 months of planned transfer to adult diabetes care
You may not qualify if:
- Other life-threatening disease (e.g. cancer) or major psychiatric disorder (e.g. schizophrenia) that significantly limits participation
- Pervasive developmental disorder that significantly limits participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's National Health System
Washington D.C., District of Columbia, 20010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
A total of 52 participants were enrolled in the trial (planned enrollment: 100 participants). This trial was impacted by the COVID-19 pandemic.
Results Point of Contact
- Title
- Dr. Randi Streisand
- Organization
- Children's National
Study Officials
- PRINCIPAL INVESTIGATOR
Randi Streisand, PhD
Children's National Research Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 1, 2018
First Posted
November 7, 2018
Study Start
November 6, 2018
Primary Completion
December 1, 2023
Study Completion
January 2, 2026
Last Updated
May 5, 2026
Results First Posted
May 5, 2026
Record last verified: 2026-05